Capital Health Earns National Reaccreditation for Radiation Oncology

American College of Radiology

Capital Health’s Radiation Oncology Department, part of the Center for Oncology at Capital Health Medical Center – Hopewell, has been awarded a three-year term of reaccreditation in radiation oncology following a review by the American College of Radiology (ACR). Radiation oncology (radiation therapy) is the careful use of high energy radiation to treat cancer. A radiation oncologist may use radiation to treat cancer or to relieve a cancer patient’s pain.

“After a comprehensive peer review process and assessment of our personnel, technology, and treatment practices, the ACR’s onsite survey team determined that we meet their rigorous guidelines,” said Dr. Shirnett Williamson, medical director of Radiation Oncology Services at Capital Health. “In their final report, the survey team made special note of our staff’s meticulous organization and commitment to excellence in delivery of care.”

“With this reaccreditation, the highly skilled professionals in our Radiation Oncology Department show the community we are up to date on current best practices and meet strict national standards,” said Dr. Timothy Chen, medical director of Stereotactic Radiosurgery at Capital Health. “Meeting these technical benchmarks empowers us to provide safe, compassionate care to our patients every day.”

Combining technologies such as the TrueBeamTM Linear Accelerator and CyberKnife® Robotic Radiosurgery System, our Radiation Oncology team at the Capital Health Center for Oncology is proud to be one of only a few programs in the country to have two of the most advanced radiation devices under one roof to provide the most efficient treatment plans for patients. As the first hospital in the region to offer the TrueBeam Linear Accelerator, our experienced multidisciplinary team can manage challenging cancers with unparalleled ease and precision anywhere in the body, including the lung, liver, prostate, abdomen, pelvis, breast, head and neck. TrueBeam rotates around the patient to deliver a prescribed radiation dose from nearly any angle, and it can be used to perform traditional 3D conformal radiation therapy, intensity modulated radiation therapy (IMRT), RapidArc® radiotherapy, and stereotactic radiosurgery.

We also have the most experienced team in the region when it comes to CyberKnife® Radiosurgery, a non-invasive procedure used to treat tumors of the brain, spine and other areas throughout the body. As the first in the region to offer CyberKnife® Radiosurgery, our team is able to sculpt radiation beams with extraordinary accuracy to reach small, deeply imbedded, complex tumors and lesions once considered inoperable while minimizing damage to healthy surrounding tissue.

Using CyberKnife®, our team is able to treat tumors of the brain, spine, lung, liver, pancreas and prostate. It can also treat other conditions such as:

  • Benign brain tumors such as acoustic neuromas, meningiomas, pituitary adenomas,  raniopharngiomal hemangioblastoma, schwannomas
  • Malformations of blood vessels within the brain, such as arteriovenous malformations (AVMs)
  • Trigeminal neuralgia
  • Metastatic orbital tumors and orbital lymphomas

Our Radiation Oncology Department also offers High Dose Rate (HDR) radiation therapy. Using HDR, our staff can treat cancer by placing radioactive sources directly into or next to the cancer, which enables us to deliver a high dose with minimal impact to surrounding healthy tissue. HDR has proven to be a successful treatment for cancers of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, head and neck, and soft tissue sarcoma.

To learn more about Capital Health’s Center for Oncology, visit capitalhealth.org/oncology.

Who is the American College of Radiology?

The ACR is the nation’s oldest and most widely accepted radiation oncology accrediting body. The ACR seal of accreditation is awarded only to facilities that, like Capital Health, meet specific practice guidelines and technical standards developed by the ACR after a peer review evaluation by board certified radiation oncologists and medical physicists who are experts in the field.

Back to top